Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

TSHA

Taysha Gene Therapies, Inc.

CIK 0001806310 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$6.09
↓ 0.02 (-0.33%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals

Key stats

Market Cap
$1.98B
P/E Ratio
-13.26
EPS
-0.34
Dividend Yield
Not covered
52W Position
74%
Beta
1.85

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
5.12
P/S
361.77
EV/Revenue
287.73
ROE
-38.6%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 74%
$2.71$7.30

Latest Financials

2025-12-31 FY
Revenue
$9.77M
Net Income
-$109.00M
Total Assets
$343.32M
Free Cash Flow
-$93.83M

Recent news